Gilead, Teva Document Disclosures Helped Sway Jury In Rare Pay-For-Delay Trial

 
• By Brenda Sandburg
  
HIV gavel
A jury found the Gilead-Teva HIV drug patent settlement agreement was not anticompetitive. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet